MABION S.A.

MAB
End-of-day quote. End-of-day quote  - 12/01
75.2PLN +2.17%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The Company specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. It focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. It operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.
Managers
Name Title
Krzysztof Kaczmarczyk President-Management Board & CEO
Grzegorz Mariusz Grabowicz Chief Financial Officer
Robert Leszek Konski Chairman-Supervisory Board
Slawomir Jaros Chief Operating & Scientific Officer
David John James Independent Member-Supervisory Board
Slawomir Kosciak Member-Supervisory Board
Zofia Szewczuk Independent Member-Supervisory Board
Józef Antoni Banach Independent Member-Supervisory Board
Maciej Wieczorek Deputy Chairman-Supervisory Board
Wojciech Wosko Member-Supervisory Board
Shareholders
Name Equities %
Twiti Investment Ltd. 2,674,617 16.5%
Investors TFI SA 1,502,649 9.30%
Polfarmex SA 1,474,346 9.12%
Maciej Wieczorek 1,097,135 6.79%
Generali PTE SA 888,456 5.50%
Nationale-Nederlanden PTE SA 875,555 5.42%
Celon Pharma S.A. 620,350 3.84%
Deka Investment GmbH 316,665 1.96%
Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SA 64,774 0.40%
ESALIENS TFI SA 56,023 0.35%
Company contact information
Mabion SA
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki, Lodz 95-050

Phone : +48.42.290.8210
Fax : +48.42.355.1777
Web : http://www.mabion.eu
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
MABION S.A.262.41%288
GILEAD SCIENCES, INC.18.31%86 465
BIONTECH SE331.48%84 953
WUXI APPTEC CO., LTD.30.33%66 734
REGENERON PHARMACEUTICALS31.76%66 553
VERTEX PHARMACEUTICALS-20.90%47 530
BEIGENE, LTD.34.50%32 613
GENMAB A/S3.05%25 290
ARGENX SE2.07%14 342
ACCELERON PHARMA INC.39.71%10 932
HUALAN BIOLOGICAL ENGINEERING INC.-32.50%8 284
NEUROCRINE BIOSCIENCES, INC.-13.15%7 898
ASCENDIS PHARMA A/S-17.84%7 772
MIRATI THERAPEUTICS, INC.-37.73%7 552
ARROWHEAD PHARMACEUTICALS, INC.-8.71%7 322
SAREPTA THERAPEUTICS, INC.-52.60%7 037
GW PHARMACEUTICALS PLC89.72%6 907
LEGEND BIOTECH CORPORATION82.92%6 851
REMEGEN CO., LTD.8.95%6 647
MARAVAI LIFESCIENCES HOLDINGS, INC.63.78%6 039
BIOCON LIMITED-22.56%5 706
Brand Portfolio
» More brands of Mabion S.A.